STAT3 and melanoma: Because we have shown CDDO-Me-mediated attenuation of IL-6 production and STAT3 activation in melanoma-conditioned macrophages, we hypothesize that inhibition of JAK/STAT3 signaling is likely one of the mechanisms by which CDDO-Me inhibits tumor progression.